As a schizophrenia susceptibility gene, DTNBP1 risk polymorphisms and haplotypes are associated with negative symptoms, cognition decline, early visual processing deficits and prefrontal brain function impairment in schizophrenia patients [68–74]. This evidence concerns the gene DTNBP1 and schizophrenia.